Volume 9, Issue 6 (November & December 2018)                   BCN 2018, 9(6): 389-396 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Asehinde S, Ajayi A, Bakre A, Omorogbe O, Adebesin A, Umukoro S. Effects of Jobelyn® on Isoniazid-Induced Seizures, Biomarkers of Oxidative Stress and Glutamate Decarboxylase Activity in Mice. BCN. 2018; 9 (6) :389-396
URL: http://bcn.iums.ac.ir/article-1-980-en.html
1- Department of Pharmacology and Therapeutics, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Abstract:  

Introduction: Isoniazid-induced seizure, often described as Status Epilepticus (SE), is an emergency condition characterized by repeated convulsive episodes that responds poorly to the currently available anticonvulsant drugs. The current study aimed at ascertaining the effect of Jobelyn® (JB), an African dietary supplement, on seizures, altered oxidative stress, and glutamate decarboxylase activity induced by isoniazid in mice.
Methods: A total of 6 mice received JB (10-50 mg/kg, PO), pyridoxine (300 mg/kg), diazepam (5 mg/kg), or distilled water (10 mL/kg) 30 minutes prior to the induction of SE with injection of isoniazid (300 mg/kg, IP). Thereafter, the mice were observed for the onset of convulsions for a period of two hours. Moreover, the effect of JB on Glutamate Decarboxylase (GAD) activity and biomarkers of oxidative stress (glutathione and malondialdehyde) was also evaluated in the brain homogenates of another set of isoniazid-treated mice.
Results: JB (50 mg/kg, PO) prolonged the latency to convulsions, but could not prevent the occurrence of seizure episodes caused by isoniazid. Moreover, JB neither showed any protection against death nor delayed the latency to death caused by isoniazid. However, this dose of JB positively modulated the concentrations of malondialdehyde and glutathione in the brains of mice treated with isoniazid. The activity of GAD, the enzyme responsible for GABA synthesis, increased by JB, which suggested enhanced GABAergic neurotransmission.
Conclusion: The current study findings suggest that JB prolongs the latency to convulsions, enhances GABAergic neurotransmission, and demonstrates anti-oxidative effect in isoniazid-treated mice.
Type of Study: Original | Subject: Behavioral Neuroscience
Received: 2017/07/13 | Accepted: 2018/03/3 | Published: 2018/11/1

References
1. Adebayo, J. A., Oyagbemi, A. A., Akintunde, J. K., Akinyinka, E. O., & Arojojoye, O. (2012). Microsomal lipid peroxidation, antioxidant enzyme activities in brain of male rats during long-term exposure to isoniazid. Journal of Drug Metabolism and Toxicology, 3(4), 127-30. [DOI:10.4172/2157-7609.1000127] [DOI:10.4172/2157-7609.1000127]
2. Ahadpour, M., Eskandari, M. R., Mashayekhi, V. Haj Mohammad Ebrahim Tehrani, K., Jafarian, I., et al. (2016). Mitochondrial oxidative stress and dysfunction induced by isoniazid: Study on isolated rat liver and brain mitochondria. Drug and Chemical Toxicology, 39(2), 224-32. [DOI:10.3109/01480545.2015.1092039] [PMID] [DOI:10.3109/01480545.2015.1092039]
3. Bassin, S., Smith, T. L., & Bleck, T. P. (2002). Clinical review: Status epilepticus. Critical Care, 6(2), 137-42. [DOI:10.1186/cc1472] [PMID] [PMCID] [DOI:10.1186/cc1472]
4. Benson, K. F., Beaman, J. L., Ou, B., Okubena, A., Okubena, O., & Jensen, G. S. (2013). West African Sorghum bicolor leaf sheaths have anti-inflammatory and immune-modulating properties in vitro. Journal of Medicinal Food, 16(3), 230-8. [DOI:10.1089/jmf.2012.0214] [PMID] [PMCID] [DOI:10.1089/jmf.2012.0214]
5. Bonner, A. B., Peterson, S. L., & Weir, M. R. (1999). Seizures induced by theophylline and isoniazid in mice. Veterinary and Human Toxicology, 41(3), 175-7. [PMID] [PMID]
6. Bronstein, A. C., Spyker, D. A., Cantilena, L. R., Green, J. L., Rumack, B. H., & Dart, R. C. (2010). Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 28th annual report. Clinical Toxicology, 49, 910-941. [DOI:10.3109/15563650.2011.635149] [PMID] [DOI:10.3109/15563650.2011.635149]
7. Brophy, G. M., Bell, R., Claassen, J., Alldredge, B., Bleck, T. P., & Glauser, T. (2012). Guidelines for the evaluation and management of status epilepticus. Neurocritical Care, 17(1), 3-23. [DOI:10.1007/s12028-012-9695-z] [PMID] [DOI:10.1007/s12028-012-9695-z]
8. Cevik, M. U., Acar, A., Tanriverdi, H., Varol, S., Arikanoglu, A., Yucel, Y., et al. (2012). Toxic effects of isoniazid and rifampicin on rat brain tissue: The preventive role of caffeic acid phenethyl ester. International Journal of Pharmacology, 8(6), 555-60. [DOI:10.3923/ijp.2012.555.560] [DOI:10.3923/ijp.2012.555.560]
9. Cicek, E., Sutccu, R., Gokalp, O., Yilmaz, H. R., Ozer, M. K., Uz, E., et al. (2005). The effects of isoniazid on hippocampal NMDA receptors: Protective effect of erdosteine. Molecular and Cellular Biochemistry, 277(1-2), 131-5. [DOI:10.1007/s11010-005-5778-x] [PMID] [DOI:10.1007/s11010-005-5778-x]
10. Corda, M. G., Costa, E., & Guidotti, A. (1982). Specific proconvulsant action of an imidazobenzodiazepine (Ro 15-1788) on isoniazid convulsions. Neuropharmacology, 21(1), 91-4. [DOI:10.1016/0028-3908(82)90217-9] [DOI:10.1016/0028-3908(82)90217-9]
11. Cozzani, I. (1970). Spectrophotometric assay of L-glutamic acid decarboxylase. Analytical Biochemistry, 33(1), 125-31. [DOI:10.1016/0003-2697(70)90446-X] [DOI:10.1016/0003-2697(70)90446-X]
12. DeLorenzo, R. J., Towne, A. R., Pellock, J. M., & Ko, D. (1992). Status epilepticus in children, adults, and the elderly. Epilepsia, 33(S4), 15-25. [DOI:10.1111/j.1528-1157.1992.tb06223.x] [DOI:10.1111/j.1528-1157.1992.tb06223.x]
13. Hauser, W. A. (1990). Status epilepticus: Epidemiologic considerations. Neurology, 40(5 Suppl 2), 9-13. [PMID] [PMID]
14. Franco, R., Schonveld, O. J., Pappa, A., & Panayiotidis, M. I. (2007). Central role of glutathione in the pathophysiology of human diseases. Archives of Physiology and Biochemistry, 113(4-5), 234-58. [DOI:10.1080/13813450701661198] [PMID] [DOI:10.1080/13813450701661198]
15. Kendall, D. A., Fox, D. A., & Enna, S. J. (1981). Anticonvulsant profile of gamma vinyl GABA. Neuropharmacology, 20(20), 4-10.
16. McNamara, J. O. (1994). Cellular and molecular basis of epilepsy. Journal of Neuroscience, 14(6), 3413-25. [DOI:10.1523/JNEUROSCI.14-06-03413.1994] [PMID] [DOI:10.1523/JNEUROSCI.14-06-03413.1994]
17. Mahmoud, A. M., Germoush, M. O., & Soliman, A. S. (2014). Berberine attenuates isoniazid-induced hepatotoxicity by modulating perixosome proliferator- activated receptor y, oxidative and inflammation. International Journal of Pharmacology, 10(8), 451-60. [DOI:10.3923/ijp.2014.451.460] [DOI:10.3923/ijp.2014.451.460]
18. Meierkord, H., Boon, P., & Engelsen, B. (2010). EFNS guideline on the management of status epilepticus in adults. European Journal of Neurology, 17(30), 348-55. [DOI:10.1111/j.1468-1331.2009.02917.x] [PMID] [DOI:10.1111/j.1468-1331.2009.02917.x]
19. Minns, A. B., Ghafouri, N., & Clark, R. F. (2010). Isoniazid-induced status epilepticus in a pediatric patient after inadequate pyridoxine therapy. Pediatric Emergency Care, 26(5), 380-1. [DOI:10.1097/PEC.0b013e3181db24b6] [PMID] [DOI:10.1097/PEC.0b013e3181db24b6]
20. Moreira, P. I., Santos, M. S., Oliveira, C. R., Shenk, J. C., Nunomura, A., Smith, M. A., et al. (2008). Alzheimer disease and the role of free radicals in the pathogenesis of the disease. CNS Neurological Disorder and Drug Targets, 7(1), 3-10. [DOI:10.2174/187152708783885156] [PMID] [DOI:10.2174/187152708783885156]
21. Moron, M. S., Depierre, J. W., & Mannervik, B. (1979). Levels of glutathione, glutathione reductase and glutathione transferase activities in rat lung and liver. Biochimica et Biophysica ACTA, 582(1), 67-78. [DOI:10.1016/0304-4165(79)90289-7] [DOI:10.1016/0304-4165(79)90289-7]
22. Natalie, A., Kelsey, I., Heather, M., Wilkins, I., & Linseman, D. A. (2010). Nutraceuticalantioxidants as novel neuroprotective agents. Molecules, 15(11), 7792–814. [DOI:10.3390/molecules15117792] [PMID] [PMCID] [DOI:10.3390/molecules15117792]
23. Ohkawa, H., Ohishi, N., & Yagi, K. (1970). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry, 95(2), 351-8. [DOI:10.1016/0003-2697(79)90738-3] [DOI:10.1016/0003-2697(79)90738-3]
24. Okochi, V. I., Okpuzor, J., Okubena, M. O., & Awoyemi, A. K. (2003). The influence of African herbal formular on the haematological parameters of trypanosome infected rats. African Journal of Biotechnology, 2(9), 312-6. [DOI:10.5897/AJB2003.000-1064] [DOI:10.5897/AJB2003.000-1064]
25. Oshikoya, K. A., Senbanjo, I. O., Njokanma, O. F., & Soipe, A. (2008). Use of complementary and alternative medicines for children with chronic health conditions in Lagos, Nigeria. BMC Complementary and Alternative Medicine, 8(1), 66. [DOI:10.1186/1472-6882-8-66] [PMID] [PMCID] [DOI:10.1186/1472-6882-8-66]
26. Oyinbo, C. A., Dare, W. N., Avwioro, O. G., & Igbigbi, P. S. (2015). Neuroprotective effect of Jobelyn in the hippocampus of alcoholic rat is mediated in part by alterations in GFAP and NF protein expressions. Advances in Biological Research, 9(5), 305-17.
27. Romero, J. A., & Kuczler, F. J. (1998). Isoniazid overdose. Recognition and Management. American Family Physician, 57(4), 749-52. [PMID] [PMID]
28. Tajender, V., & Saluja, J. (2006). INH induced status epilepticus: Response to pyridoxine. Indian Journal of Chest Diseases and Allied Sciences, 48(3), 205-6. [PMID] [PMID]
29. Umukoro, S., Oluwole, O. G., Eduviere, A. T., Adrian, O. I., & Ajayi, A. M. (2015). Jobelyn® exhibited anti-inflammatory, antioxidant, and membrane-stabilizing activities in experimental models. Journal of Basic and Clinical Physiology and Pharmacology, 26(5), 501-8. [DOI:10.1016/j.brainresbull.2015.11.016] [PMID] [DOI:10.1016/j.brainresbull.2015.11.016]
30. Umukoro, S., Omogbiya, I. A., & Eduviere, A. T. (2013). Evaluation of the effect of jobelyn® on chemoconvulsants-induced seizure in mice. Basic and Clinical Neuroscience, 4(2), 125-9. [PMID] [PMCID]
31. Uzman, S., Yanaral, T. U., Toptaş, M., Koç, A., Taş, A., & Bican, G. (2013). Acute isoniazid intoxication: An uncommon cause of convulsion, coma and acidosis. Tüberküloz ve Toraks, 61(1), 50-3. [DOI:10.5578/tt.1897] [PMID] [DOI:10.5578/tt.1897]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


© 2019 All Rights Reserved | Basic and Clinical Neuroscience

Designed & Developed by : Yektaweb